SynAct Pharma

14,30 SEK

-3,77%

Mindre end 1K følgere

SYNACT

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for SynAct Pharma

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)7,9943,70140,4680,768,758,9722,60
Aktier14,924,726,229,935,946,553,3
Markedsværdi118,91.081,23.680,82.416,3314,1416,81.205,3
Enterprise value115,31.066,63.659,82.310,2252,3357,4-
EV/S-------
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B8,8068,14176,3719,101,781,957,08
P/S-------
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio56,7 %73,5 %54,4 %88,7 %77,3 %79,2 %77,2 %
Gearing ratio--14,8 %1,6 %0,4 %0,9 %0,7 %